TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
Wei Xu(Nanjing Medical University), Jianwei Zhou(Nanjing Medical University)
Cited by 84
Related Papers
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
|Cell Death and Disease|2014|58
JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis
|Journal of Experimental & Clinical Cancer Research|2020|55
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
|Cell & Bioscience|2015|50
miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation
|Oncotarget|2014|43
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
|Cancer Cell International|2021|41